Skip to content Skip to footer

Research Portal of the TU Dresden

Annals of Hematology

ISSNs: 0939-5555, 1269-3286, 1279-8509, 0029-4810, 0370-4386

Additional searchable ISSN (electronic): 1432-0584

Springer Verlag

Scopus rating (2023): CiteScore 5.6 SJR 0.912 SNIP 0.948

Journal

Titles	Annals of Hematology Annals of hematology Hematology and Cell Therapy Nouvelle Revue Francaise d'Hematologie Revue d'hématologie
Additional searchable titles	Annals of hematology, Ann Hematol
ISSNs	0939-5555, 1269-3286, 1279-8509, 0029-4810, 0370-4386
Additional searchable ISSN (electronic)	1432-0584
Publisher	Springer Verlag
ZDB-ID	1064950-5
ZDB-ID	1458429-3

Keywords

ASJC Scopus subject areas

Hematology

Library keywords

610 Medicine and health

Related content

Research output

VEXAS syndrome: complete molecular remission after hypomethylating therapy

Sockel, K., Götze, K., Ganster, C., Bill, M., Georgi, J-A., Balaian, E., Aringer, M., & 5 othersTrautmann-Grill, K., Uhlig, M., Bornhäuser, M., Haase, D. & Thiede, C., Mar 2024, In: Annals of hematology. 103, 3, p. 993-997 5 p.

Research output: Contribution to journal › Research article › Contributed › peer-review

Prevalence of anemia at diagnosis of pediatric chronic myeloid leukemia and prognostic impact on the disease course

Delehaye, F., Rouger, J., Brossier, D., Suttorp, M., Güneş, A. M., Sedlacek, P., Versluys, B., & 11 othersLi, C. K., Kalwak, K., Lausen, B., Srdjana, C., Dworzak, M., Hraskova, A., De Moerloose, B., Roula, F., Briant, A., Parienti, J. J. & Millot, F., Mar 2023, In: Annals of hematology. 102, 3, p. 563-570 8 p.

Research output: Contribution to journal › Research article › Contributed › peer-review

Effects of rigosertib on the osteo-hematopoietic niche in myelodysplastic syndromes

Balaian, E., Weidner, H., Wobus, M., Baschant, U., Jacobi, A., Mies, A., Bornhäuser, M., & 4 othersGuck, J., Hofbauer, L. C., Rauner, M. & Platzbecker, U., 1 Sept 2019, In: Annals of hematology. 98, 9, p. 2063-2072 10 p.

Research output: Contribution to journal › Research article › Contributed › peer-review

Phase II clinical trial of pazopanib in patients with acute myeloid leukemia (AML), relapsed or refractory or at initial diagnosis without an intensive treatment option (PazoAML)

Kessler, T., Koschmieder, S., Schliemann, C., Crysandt, M., Mikesch, J-H., von Stillfried, S., Stelljes, M., & 11 othersPohlen, M., Lenz, G., Kirsch, A., Vehring, K., Wardelmann, E., Hartmann, W., Bormann, E., Gerss, J., Brümmendorf, T. H., Müller-Tidow, C. & Berdel, W. E., Jun 2019, In: Annals of hematology. 98, 6, p. 1393-1401 9 p.

Research output: Contribution to journal › Research article › Contributed › peer-review

Six versus eight doses of rituximab in patients with aggressive B cell lymphoma receiving six cycles of CHOP: results from the "Positron Emission Tomography-Guided Therapy of Aggressive Non-Hodgkin Lymphomas" (PETAL) trial

Hüttmann, A., Rekowski, J., Müller, S. P., Hertenstein, B., Franzius, C., Mesters, R., Weckesser, M., & 46 othersKroschinsky, F., Kotzerke, J., Ganser, A., Bengel, F. M., La Rosée, P., Freesmeyer, M., Höffkes, H-G., Hertel, A., Behringer, D., Prange-Krex, G., Griesshammer, M., Holzinger, J., Wilop, S., Krohn, T., Raghavachar, A., Maschmeyer, G., Brink, I., Schroers, R., Gaska, T., Bernhard, H., Giagounidis, A., Schütte, J., Dienst, A., Hautzel, H., Naumann, R., Klein, A., Hahn, D., Pöpperl, G., Grube, M., Marienhagen, J., Schwarzer, A., Kurch, L., Höhler, T., Steiniger, H., Nückel, H., Südhoff, T., Römer, W., Brinkmann, M., Ose, C., Alashkar, F., Schmitz, C., Dürig, J., Hoelzer, D., Jöckel, K-H., Klapper, W. & Dührsen, U., Apr 2019, In: Annals of hematology. 98, 4, p. 897-907 11 p.

Research output: Contribution to journal › Research article › Contributed › peer-review

View all research output (17)